Fundraising Fox

MicroTransponder

NASDAQ: MOBI

Austin, US · Founded 2007 · Delaware corporation · 3 known investors

microtransponder.com

Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved treatment for stroke survivors with moderate to severe upper extremity impairment. The company delivers clinically validated recovery solutions specifically for chronic ischemic stroke patients.

Digital HealthHealthtechMedical Devices

Founders & leadership

RJ
Richard John FoustExecutive
FM
Frank McEachernExecutive

Board

NB
Nelson Bunker CurnesBoard director
TJ
Thomas Jordan Curnes IIBoard director
CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
DM
Dana MeadBoard director
BH
Bill HarringtonBoard director
CL
Cythia LuccheseBoard director
TJ
Thomas J. CurnesBoard director
CM
Chuck MiddlekaufBoard director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$108.2M disclosed across 7 rounds · 2015–2025

$32.5MraisedMar 2025 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard John FoustExecutive Officer, Director
  • Nelson Bunker CurnesExecutive Officer, Director
  • Thomas Jordan Curnes IIExecutive Officer, Director
  • Casey TanseyDirector
  • Dana MeadDirector
  • Bill HarringtonDirector
  • Cythia LuccheseDirector
Offering amount
$65M
Amount sold
$32.5M
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$42.9MraisedSep 2022 · 41 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas Jordan Curnes IIExecutive Officer, Director
  • Bill HarringtonDirector
  • Casey TanseyDirector
  • Richard John FoustExecutive Officer, Director
  • Nelson Bunker CurnesExecutive Officer, Director
Offering amount
$72.9M
Amount sold
$42.9M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6MraisedAug 2021 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nelson Bunker CurnesExecutive Officer, Director
  • Thomas Jordan Curnes IIExecutive Officer, Director
  • Thomas CurnesDirector
  • Chuck MiddlekaufDirector
Offering amount
$6M
Amount sold
$6M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5.8MraisedSep 2020 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nelson Bunker CurnesDirector
  • Thomas J. CurnesDirector
  • T. Jordan Curnes IIExecutive Officer, Director
  • Chuck MiddlekaufDirector
  • Frank McEachernExecutive Officer, Director
Offering amount
$6M
Amount sold
$5.8M
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$11.6MraisedNov 2017 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank McEachernExecutive Officer, Director
  • Chuck MiddlekaufDirector
  • Thomas J. CurnesDirector
  • N. Bunker CurnesDirector
  • T. Jordan Curnes IIExecutive Officer, Director
Offering amount
$16.6M
Amount sold
$11.6M
First sale
Nov 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5.5MraisedJul 2017 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chuck MiddlekaufDirector
  • N. Bunker CurnesDirector
  • Frank McEachernExecutive Officer, Director
  • Thomas J. CurnesDirector
  • T. Jordan Curnes IIExecutive Officer, Director
Offering amount
$6M
Amount sold
$5.5M
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.9MraisedSep 2015 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas J. CurnesDirector
  • Chuck MiddlekaufDirector
  • Frank McEachernExecutive Officer, Director
  • N. Bunker CurnesDirector
  • T. Jordan Curnes IIExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$3.9M
First sale
Sep 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 10 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$224.3K
National Institutes of Health (NIH)National Institutes of HealthPhase I2013$225K
National Institutes of Health (NIH)National Institutes of HealthPhase II2012$2.6M
National Institutes of Health (NIH)National Institutes of HealthPhase II2011$2.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2010$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$286.4K
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$175K
National Institutes of Health (NIH)National Institutes of HealthPhase I2009$239K
National Institutes of Health (NIH)National Institutes of HealthPhase I2009$96.6K
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2008$113.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does MicroTransponder do?
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved treatment for stroke survivors with moderate to severe upper extremity impairment. The company delivers clinically validated recovery solutions specifically for chronic ischemic stroke patients.
Who are MicroTransponder's investors?
MicroTransponder's investors include Longitude Capital, UT Horizon Fund, US Venture Partners.
How much funding has MicroTransponder raised?
MicroTransponder has disclosed $108.2M raised across 7 rounds.
Where is MicroTransponder headquartered?
MicroTransponder is headquartered in Austin, US.